| Detailed information |
|---|
| CancerLivER ID | 2532 |
| Biomarker | GPC3, NCSTN, LCN2, PLK, PSK-1, PTTG1 |
| Biomarker Name/Symbol (given in Publication) | GPC3, NCSTN, LCN2, PLK, PSK-1, PTTG1 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Diagnostic markers, or therapeutic targets of HCC and validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC than non-tumorous tissue |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 15735714 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | Training dataset: 156 samples, including 82 HCC (where there were multiple samples from different tumor nodules of the same patient, only one representative sample was used) and 74 nontumor liver tissues; Validation dataset: paired HCC and adjacent nontumor liver tissue from 8 patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2005 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |